The charts are showing this biotech stock can strengthen into year-end
While the major equity indexes have experienced a choppy Q4, a number of groups within the health care sector have shown strong resilience. Pharmaceuticals and biotechs have generally outperformed the S & P 500 since the end of September, suggesting a potential safe haven play for investors concerned about market instability. Today, we profile one…